International Journal of Molecular Sciences:晚期前列腺癌的免疫治疗——隧道尽头的光?

International Journal of Molecular Sciences:Immunotherapy in advanced prostate cancer-light at the end of the tunnel?

在很多实体瘤中免疫治疗已经成为一种标准治疗方案,然而,免疫治疗在前列腺癌中的探索仍未转化为临床实践。前列腺癌高度免疫抑制的"冷"肿瘤微环境降低了很多免疫治疗方案的疗效,包括免疫检查点抑制剂。随着对于肿瘤-免疫系统相互作用了解的深入,研发人员重新看到了未来在前列腺癌中优化免疫治疗策略的希望。本篇综述旨在提供前列腺癌免疫治疗的最新进展及展望未来的发展方向,帮忙医生更好地了解临床前和临床开发中的治疗策略。

Immunotherapeutic treatment approaches are now an integral part of the treatment of many solid tumors.However,attempts to integrate immunotherapy into the treatment of prostate cancer have been disappointing so far.This is due to a highly immunosuppressive,"cold" tumor microenvironment.The consequence is a reduced efficacy of many established immunotherapeutic treatments such as checkpoint inhibitors.However,a growing understanding of the underlying mechanisms of tumor-immune system interactions raises hopes that immunotherapeutic strategies can be optimized in the future.The aim of this review is to provide an overview of the current status and future directions of immunotherapy development in prostate cancer,and to better understand current therapeutic strategies under preclinical and clinical development.